Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.
Author Title [ Type(Asc)] Year
Filters: Keyword is Humans  [Clear All Filters]
Journal Article
Savarese JJ.  1981.  The new neuromuscular blocking drugs are here.. Anesthesiology. 55(1):1-3.
Donlon JV, Ali HH, Savarese JJ.  1974.  A new approach to the study of four nondepolarizing relaxants in man.. Anesth Analg. 53(6):934-9.
Perouansky M, Hemmings HC.  2009.  Neurotoxicity of general anesthetics: cause for concern? Anesthesiology. 111(6):1365-71.
Grobelny BT, Rubin D, Fleischut P, Rubens E, Mack PFogarty, Fink M, Placantonakis DG, Elowitz EH.  2012.  Neurosurgical management of symptomatic thoracic spinal ossification in a patient with fibrodysplasia ossificans progressiva.. J Neurosurg Spine. 16(3):285-8.
Hemmings HC.  2004.  Neuroprotection by Na+ channel blockade.. J Neurosurg Anesthesiol. 16(1):100-1.
Goudsouzian NG, Ryan JF, Savarese JJ.  1974.  The neuromuscular effects of pancuronium in infants and children.. Anesthesiology. 41(1):95-8.
Kopman AF, Lien CA, Naguib M.  2011.  Neuromuscular dose-response studies: determining sample size.. Br J Anaesth. 106(2):194-8.
Boros EE, Samano V, Ray JA, Thompson JB, Jung DK, Kaldor I, Koble CS, Martin MT, Styles VL, Mook RA et al..  2003.  Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys.. J Med Chem. 46(12):2502-15.
Goudsouzian NG, Alifimoff JK, Eberly C, Smeets R, Griswold J, Miler V, McNulty BF, Savarese JJ.  1989.  Neuromuscular and cardiovascular effects of mivacurium in children.. Anesthesiology. 70(2):237-42.
Goudsouzian NG, Alifimoff JK, Liu LM, Foster V, McNulty B, Savarese JJ.  1989.  Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane.. Br J Anaesth. 62(3):263-8.
Hung JC, Azam N, Puttanniah V, Malhotra V, Gulati A.  2014.  Neurolytic transversus abdominal plane block with alcohol for long-term malignancy related pain control.. Pain Physician. 17(6):E755-60.
Pamnani A, Rosenstein M, Darwich A, Wolfson A.  2010.  Neuraxial anesthesia for labor and cesarean delivery in a parturient with hereditary antithrombin deficiency on recombinant human antithrombin infusion therapy.. J Clin Anesth. 22(6):450-3.
Lien CA.  2010.  Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent? Anesthesiology. 112(1):16-8.
Lien CA.  2012.  A need to establish programs to detect and prevent drug diversion.. Mayo Clin Proc. 87(7):607-9.
Ryan TA.  2001.  NCAM and vesicle cycling: the importance of good glue in the long run.. Neuron. 32(5):759-61.
Lien CA, Belmont MR, Abalos A, Hass D, Savarese JJ.  1999.  The nature of spontaneous recovery from mivacurium-induced neuromuscular block.. Anesth Analg. 88(3):648-53.
Pryor KO, Hemmings HC.  2014.  NAP5: intraoperative awareness detected, and undetected.. Br J Anaesth. 113(4):530-3.
Savarese JJ, Lowenstein E.  1985.  The name of the game: no anesthesia by cookbook.. Anesthesiology. 62(6):703-5.
Mitchell MM, Ali HH, Savarese JJ.  1978.  Myotonia and neuromuscular blocking agents.. Anesthesiology. 49(1):44-8.
Perry NW, McCoy JG, Cunningham WR, Falgout JC, Street WJ.  1976.  Multivariate visual evoked response correlates of intelligence.. Psychophysiology. 13(4):323-9.
Ali HH, Savarese JJ.  1976.  Monitoring of neuromuscular function.. Anesthesiology. 45(2):216-49.
Liantonio A, Picollo A, Carbonara G, Fracchiolla G, Tortorella P, Loiodice F, Laghezza A, Babini E, Zifarelli G, Pusch M et al..  2008.  Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.. Proc Natl Acad Sci U S A. 105(4):1369-73.
Liantonio A, Accardi A, Carbonara G, Fracchiolla G, Loiodice F, Tortorella P, Traverso S, Guida P, Pierno S, De Luca A et al..  2002.  Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid.. Mol Pharmacol. 62(2):265-71.
Picollo A, Liantonio A, Didonna MPaola, Elia L, Camerino DConte, Pusch M.  2004.  Molecular determinants of differential pore blocking of kidney CLC-K chloride channels.. EMBO Rep. 5(6):584-9.
Kopman AF, Klewicka MM, Kopman DJ, Neuman GG.  1999.  Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration.. Anesthesiology. 90(2):425-31.